111 related articles for article (PubMed ID: 7950374)
1. Purification of recombinant Shiga-like toxin type I A1 fragment from Escherichia coli.
Zollman TM; Austin PR; Jablonski PE; Hovde CJ
Protein Expr Purif; 1994 Jun; 5(3):291-5. PubMed ID: 7950374
[TBL] [Abstract][Full Text] [Related]
2. Purification of recombinant shiga-like toxin type I B subunit.
Austin PR; Hovde CJ
Protein Expr Purif; 1995 Dec; 6(6):771-9. PubMed ID: 8746629
[TBL] [Abstract][Full Text] [Related]
3. One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays.
Acheson DW; Jacewicz M; Kane AV; Donohue-Rolfe A; Keusch GT
Microb Pathog; 1993 Jan; 14(1):57-66. PubMed ID: 8321118
[TBL] [Abstract][Full Text] [Related]
4. Binding of avian ovomucoid to shiga-like toxin type 1 and its utilization for receptor analog affinity chromatography.
Miyake M; Utsuno E; Noda M
Anal Biochem; 2000 Jun; 281(2):202-8. PubMed ID: 10870836
[TBL] [Abstract][Full Text] [Related]
5. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies.
Downes FP; Barrett TJ; Green JH; Aloisio CH; Spika JS; Strockbine NA; Wachsmuth IK
Infect Immun; 1988 Aug; 56(8):1926-33. PubMed ID: 3294179
[TBL] [Abstract][Full Text] [Related]
6. Purification and some properties of a Vero toxin 2 (Shiga-like toxin II) variant (SLT-IIva) of Escherichia coli isolated from infantile diarrhea.
Ohmura M; Cao C; Karasawa T; Okuda J; Kurazono H; Gannon VP; Gyles CL; Takeda Y
Microb Pathog; 1993 Nov; 15(5):399-405. PubMed ID: 8015420
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity.
Austin PR; Jablonski PE; Bohach GA; Dunker AK; Hovde CJ
Infect Immun; 1994 May; 62(5):1768-75. PubMed ID: 8168939
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of an Escherichia coli Shiga-like toxin II variant.
MacLeod DL; Gyles CL
Infect Immun; 1990 May; 58(5):1232-9. PubMed ID: 2182539
[TBL] [Abstract][Full Text] [Related]
9. An inhibitory factor for cell-free protein synthesis from Salmonella enteritidis exhibits cytopathic activity against Chinese hamster ovary cells.
Iwamaru Y; Miyake M; Arii J; Tanabe Y; Noda M
Microb Pathog; 2001 Dec; 31(6):283-93. PubMed ID: 11747376
[TBL] [Abstract][Full Text] [Related]
10. Shiga toxin attacks bacterial ribosomes as effectively as eucaryotic ribosomes.
Suh JK; Hovde CJ; Robertus JD
Biochemistry; 1998 Jun; 37(26):9394-8. PubMed ID: 9649321
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron.
Ramotar K; Boyd B; Tyrrell G; Gariepy J; Lingwood C; Brunton J
Biochem J; 1990 Dec; 272(3):805-11. PubMed ID: 2268304
[TBL] [Abstract][Full Text] [Related]
12. Cloning of genes for production of Escherichia coli Shiga-like toxin type II.
Newland JW; Strockbine NA; Neill RJ
Infect Immun; 1987 Nov; 55(11):2675-80. PubMed ID: 2822579
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of alpha-toxin of Clostridium oedematiens type A.
Izumi N; Kondo H; Ohishi I; Sakaguchi G
Jpn J Med Sci Biol; 1983 Jun; 36(3):135-46. PubMed ID: 6632349
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical and biological properties of purified Escherichia coli Shiga-like toxin II variant.
MacLeod DL; Gyles CL; Valdivieso-Garcia A; Clarke RC
Infect Immun; 1991 Apr; 59(4):1300-6. PubMed ID: 2004812
[TBL] [Abstract][Full Text] [Related]
15. A method for the purification of Shiga-like toxin 1 subunit B using a commercially available galabiose-agarose resin.
Tarragó-Trani MT; Storrie B
Protein Expr Purif; 2004 Dec; 38(2):170-6. PubMed ID: 15555932
[TBL] [Abstract][Full Text] [Related]
16. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.
Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ
J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402
[TBL] [Abstract][Full Text] [Related]
17. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies.
Donohue-Rolfe A; Acheson DW; Kane AV; Keusch GT
Infect Immun; 1989 Dec; 57(12):3888-93. PubMed ID: 2807552
[TBL] [Abstract][Full Text] [Related]
18. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2).
Oku Y; Yutsudo T; Hirayama T; O'Brien AD; Takeda Y
Microb Pathog; 1989 Feb; 6(2):113-22. PubMed ID: 2654533
[TBL] [Abstract][Full Text] [Related]
19. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin.
Noda M; Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
Microb Pathog; 1987 May; 2(5):339-49. PubMed ID: 3148810
[TBL] [Abstract][Full Text] [Related]
20. Intein-mediated fusion expression, high efficient refolding, and one-step purification of gelonin toxin.
Guo C; Li Z; Shi Y; Xu M; Wise JG; Trommer WE; Yuan J
Protein Expr Purif; 2004 Oct; 37(2):361-7. PubMed ID: 15358358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
